We are FetTech

Leaders in Regenerative Medicine- driven by science, purpose, and heart.

FetTech was founded by Danielle and Clay Fette, a husband-and-wife team whose partnership bridges clinical insight and scientific innovation. Together, they’re redefining how the world heals by developing safer, smarter, and more effective regenerative technologies.

Danielle Fette - Co-Founder & CEO

With a background in nursing and over 20 years of experience in medical devices and regenerative medicine, Danielle blends deep clinical insight with proven executive leadership.

 She has led the development and global commercialization of multiple FDA-cleared regenerative technologies trusted in medicine worldwide.

 Recognized for her transparency, strategic vision, and unwavering patient-first focus, Danielle is driven by one simple belief — we’re all going to be patients one day. Her work reflects a relentless commitment to getting safer, more effective healing solutions to those who need them — faster.

Meet The Founders

Connect with Danielle!

Clay Fette - Co-Founder & Chief Scientific Officer SEO

A pioneer in tissue engineering and biomaterials science, Clay Fette has helped develop many of the leading regenerative medical devices used in hospitals and operating rooms today.

 With decades of experience in research, product design, and clinical translation, Clay has dedicated his career to developing technologies that harness the body’s natural ability to heal itself. His innovations have been used across wound care, burn centers, trauma surgery, and reconstructive medicine, improving outcomes for patients around the world.

 Known for his scientific precision, creativity, and visionary approach, Clay leads FetTech’s R&D with a clear purpose — to advance regenerative medicine without the barriers that slow innovation. His unique ability to turn complex science into practical, life-changing solutions has made him one of the most respected minds in the field.

Connect with Clay!

Meet the Team

  • Juliet Hahn, Chief Communications Officer of FetTech.

    Juliet Hahn

    Chief Communications Officer

  • Victoria Martin, VP of Clinical & Regulatory Affairs of FetTech.

    Victoria Martin

    VP of Clinical & Regulatory Affairs

  • Laura Musgrove, Corporate Controller of FetTech.

    Laura Musgrove

    Corporate Controller

  • Ann Tamutus, Quality Assurance Manager of FetTech.

    Ann Tamutus

    Quality Assurance Manager

  • Jessica Tapia, Director of Clinical Education of FetTech.

    Jessica Tapia

    Director of Clinical Education